moderators, page-5

Rifici do you think it will get down to your entry price of 3 cents?

Rifici's post ............

I think you were referring to me. As for ramping PXS, no that is not the case. I was comparing two stocks that are on a similar path, one much more evolved than the other. I also never indicated that PXS was a buy or that it was even reasonably priced. Nor did I indicate that PRR was a sell - did you bother to read my sentiment???

Was it only 13 or 18 drugs that were approved by the FDA last year? It is getting tougher and tougher to get drugs approved and the FDA is more often than not requiring further trials which are delaying the sale of the product and also blowing out budgets for getting the drugs to market.

I even went to the effort of reading your last 20 posts in Hotcopper - seems you like to personally attack people and call them downrampers without actually positively contributing to the discussion. Still waiting for your educated response to my posts Fisherwoman. Are you capable???

NB As for Freedman's investment, keep in mind that he did it at 2.6c not at 6.5c, therefore when PRR's market cap was around $9mill not $23mill. For PRR's progress, I would be quite happy to buy $100k at around 3c as well.

I'll also be very happy to buy $100k of PRR at a higher price if they actually meet the milestones that I gauge the likelihood of success of a biotech.